- Home
- MLTX vs MGNI Comparison
MLTX vs MGNI Comparison
Compare MLTX & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLTX
- MGNI
- Stock Information
- Founded
- MLTX 2021
- MGNI 2007
- Country
- MLTX Switzerland
- MGNI United States
- Employees
- MLTX N/A
- MGNI N/A
- Industry
- MLTX Biotechnology: Pharmaceutical Preparations
- MGNI Computer Software: Programming Data Processing
- Sector
- MLTX Health Care
- MGNI Technology
- Exchange
- MLTX Nasdaq
- MGNI Nasdaq
- Market Cap
- MLTX 2.8B
- MGNI 2.5B
- IPO Year
- MLTX N/A
- MGNI N/A
- Fundamental
- Price
- MLTX $42.33
- MGNI $17.68
- Analyst Decision
- MLTX Strong Buy
- MGNI Strong Buy
- Analyst Count
- MLTX 7
- MGNI 14
- Target Price
- MLTX $84.20
- MGNI $18.39
- AVG Volume (30 Days)
- MLTX 336.5K
- MGNI 2.7M
- Earning Date
- MLTX 02-27-2025
- MGNI 02-26-2025
- Dividend Yield
- MLTX N/A
- MGNI N/A
- EPS Growth
- MLTX N/A
- MGNI N/A
- EPS
- MLTX N/A
- MGNI 0.12
- Revenue
- MLTX N/A
- MGNI $661,134,000.00
- Revenue This Year
- MLTX N/A
- MGNI $0.57
- Revenue Next Year
- MLTX N/A
- MGNI $10.16
- P/E Ratio
- MLTX N/A
- MGNI $148.63
- Revenue Growth
- MLTX N/A
- MGNI 8.71
- 52 Week Low
- MLTX $37.55
- MGNI $8.38
- 52 Week High
- MLTX $58.26
- MGNI $21.29
- Technical
- Relative Strength Index (RSI)
- MLTX 39.31
- MGNI 46.04
- Support Level
- MLTX $41.01
- MGNI $17.31
- Resistance Level
- MLTX $45.01
- MGNI $20.06
- Average True Range (ATR)
- MLTX 1.99
- MGNI 1.17
- MACD
- MLTX -0.08
- MGNI -0.21
- Stochastic Oscillator
- MLTX 17.53
- MGNI 28.37
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
About MGNI Magnite Inc.
Magnite is one of the largest supply-side platform providers, or SSP, in online advertising. The firm was previously named The Rubicon Project (an online ad exchange) and became Magnite after merging with Telaria (an SSP focused mainly on streaming video providers) in 2020. The firm also purchased another of the leading SSPs within the CTV market, SpotX, in 2021 for $1.2 billion, cementing its long-term focus on grabbing market share in this area. The firm generates nearly 45% of its revenue from the programmatic sale of CTV ad inventory, 35% from mobile online sites and apps, and the remaining from websites accessed via computer.